Nexturnbioscience to raise 14 bln won via stock sale
All News
18:45 March 31, 2022
SEOUL, March 31 (Yonhap) -- Nexturnbioscience Co.on Thursday announced that it will sell stocks to raise 14 billion won (US$11.6 million). The proceeds from the stock offering will be used primarily to finance its operations.
According to a regulatory filing, the company will issue some 3.65 million common shares at a price of 3,830 won per share. The stocks will be sold to the investors that the firm designated.
(END)
Keywords
Issue Keywords
Most Liked
-
BTS' Jimin to pre-release track on his first solo album
-
U.S. B-1B strategic bomber returns to S. Korea as N.K. fires missile
-
(URGENT) N. Korean leader Kim Jong-un calls for completing readiness for nuclear attack against enemies: KCNA
-
Main opposition slams Korea-Japan summit as 'most humiliating' moment in diplomacy
-
BTS member Jimin's single tops iTunes charts in 110 countries
Most Saved
-
Defense ministry sets out to normalize military intelligence-sharing deal with Japan
-
BTS' Jimin to pre-release track on his first solo album
-
Opposition party denounces Yoon-Kishida summit as 'shameful submission to Japan'
-
(LEAD) Political divide intensifies in S. Korea over Yoon-Kishida summit
-
U.S. B-1B strategic bomber returns to S. Korea as N.K. fires missile
-
(LEAD) S. Korea fully restores bilateral military information-sharing pact with Japan
-
N. Korea fires multiple cruise missiles toward East Sea: source
-
S. Korea, U.S. set for 'largest-ever' live-fire drills to mark alliance's 70th anniv.
-
(2nd LD) N. Korea fires multiple cruise missiles toward East Sea: S. Korean military
-
SsangYong Motor reborn as KG Mobility after takeover